(c) www.europeancancercongress.org

25th to 29th September 2015, Vienna, Austria

Reinforcing multidisciplinarity

The 18th ECCO – 40th ESMO European Cancer Congress (ECC2015) is the largest event this year to present new data and ground-breaking information to oncology professionals.  This years’ Congress is proud to introduce several other remarkable “firsts”!

For the first time, the Scientific Committee has designed an entire integrated track with sessions exploring vital synergies across tumour types and disciplines in order to take leaps of progress in overlapping areas of research.

For the first time, the scientific programme includes multidisciplinary case-sessions that mimic tumour board sessions and focus on particularly challenging cases, delivering unique practical insights to delegates.

For the first time, the programme foresees dedicated time for networking and special sessions on key policy issues and mentorship opportunities. These slots are conveniently set in the middle of the day, without conflict with scientific sessions, making it easier than ever for Congress delegates to make contacts, build key professional relationships and explore emerging areas in oncology.

Why You Should Participate

Largest European Cancer Platform:
The European Cancer Congress (ECC2015) is undoubtedly the largest European platform for presenting ground-breaking data to a global audience.

Impressive Number of Late-Breaking Abstracts Presentations:
The European Cancer Congress is renowned for attracting and presenting a remarkable number of practice-changing abstracts.

Special Late-breaking Submission Policy:
Our late-breaking submission policy is specially designed to ensure the Congress embraces all promising new developments for a very advanced, forward-looking scientific programme.

Global Impact:
The abundance of practice-changing data presented at the European Cancer Congress is widely disseminated to a global readership thanks to our worldwide media coverage generated by the hundreds of journalists attending or reporting on the Congress.

Unique Multidisciplinary Approach:
We have designed more integrated sessions bringing about dialogue and debate in overlapping areas of scientific research. The programme is therefore more streamlined, with fewer tracks, facilitating an even more productive experience for delegates.

Oncopolicy:
The European Cancer Congress remains the only European cancer meeting with a dedicated Oncopolicy track.  The Oncopolicy Forum in Amsterdam tackled topics including research, personalised medicine and care, organisation of specialised care, and translation of evidence into policy.  The recommendations derived from these discussions will be revisited at the Oncopolicy Forum in Vienna in 2015.

Patient Advocacy:
Our Patient Advocacy Track will carry forward its work in highlighting key issues for patients and survivors and exploring partnerships with all stakeholders in the oncology community.

An application has been made to the EACCME® for CME accreditation of this event:
In addition, we have enriched the programme with new elements over and above those of CME – unique mentorship opportunities and various other ways of enhancing knowledge and skills.

Find more information about the European Cancer Congress 2015 on the official Congresswebsite.
You can find the scientific programme of the ECC 2015 here.

Click here for Registration.

Tip: More up to date educational events dealing with healthcare can be found online on the Education Database »medicine & health«.